某大型三甲医院静脉用药调配中心退药风险因素分析与流程优化效果评价  

Analysis of Risk Factors and Process Optimization in Drug Return in PIVAS of a Third-Class A Hospital

作　　者：辜明 华小黎[1] 向伟[2] 蔡俐琼[2] 庄伟[3] 史琛 Gu Ming;Hua Xiaoli;Xiang Wei;Cai Liqiong;Zhuang Wei;Shi Chen(Department of Pharmacy,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Medical Affair,Huazhong University of Science and Technology,Wuhan 430022,China;Computer Management Center,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China)

机构地区：[1]华中科技大学同济医学院附属协和医院药学部,武汉430022 [2]华中科技大学同济医学院附属协和医院医务处,武汉430022 [3]华中科技大学同济医学院附属协和医院计算机管理中心,武汉430022

出　　处：《中国药师》2020年第6期1156-1159,共4页China Pharmacist

摘　　要：目的:分析武汉某大型三甲医院静脉用药调配中心(PIVAS)退药存在的风险因素,讨论存在的问题及原因,进一步优化退药流程。方法:多部门联合,通过行政干预、信息化技术干预和规范标准操作流程等措施,有效减少不合理/不规范退药。结果:流程优化后,PIVAS不规范处方量、退药数量等都有显著下降,药师工作效率提升。47个病区退药数量整体下降15.34%,病区退药数量最高下降幅度达55.45%,流程优化前后5个病区的退药数量差异有统计学意义(P<0.05)。结论:可从加强合理用药知识培训、创新技术管理、多部门联合等多个方面减少退药风险因素,提高临床合理用药水平。Objective: To investigate the risk factors in drug return in PIVAS of a third-class A hospital in Wuhan,and according to the existing problems,to optimize the procedure of drug return. Methods: Combined with administrative intervention,information technology intervention and formulating the standard operating procedure,the cases of unreasonable and non-standard drug return were reduced. Results: After optimizing the process,the number of returned drugs and irrational prescriptions were decreased significantly,and the work efficiency was also improved greatly. The amount of drug refund was decreased by 15.34% totally,and the highest decline was 55.45%. The number of returned drugs in five wards showed significant differences before and after the procedure optimization(P<0.05). Conclusion: The risk of drug refund can be reduced and the level of rational drug use in clinic can be improved by strengthening the training of rational drug use,innovative management and multi-department cooperation.

关 键 词：静脉用药调配中心 退药 风险因素 流程优化 药事管理 

分 类 号：R952[医药卫生—药学]